Pediatric PET/MR Image Registry

Description

The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.

Conditions

Soft Tissue, Lymphoma, Osteosarcoma

Study Overview

Study Details

Study overview

The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.

Pediatric PET/MR Image Registry

Pediatric PET/MR Image Registry

Condition
Soft Tissue
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Stanford University, School of Medicine, Palo Alto, California, United States, 94304

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor.
  • * We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs.
  • * Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry.
  • * Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level \> 200 mg/dl.
  • * Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age).
  • * Patient has a CNS primary tumor.
  • * Pregnant women and fetuses

Ages Eligible for Study

to 40 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Heike Daldrup-Link, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2025-03-01